Related Experiment Video
Updated: Jul 9, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Superior Outcomes of Dual-Arterial Coronary Artery Bypass Grafting Are Maintained in the Veterans Health
Ajami Gikandi1, Dinh Tran2, Zhibao Mi2
1Division of Cardiac Surgery, Veterans Affairs (VA) Boston Healthcare System and Harvard Medical School, Boston, Massachusetts; Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Insights
Dual arterial grafts (DAGs) in coronary artery bypass grafting (CABG) show improved long-term outcomes compared to single arterial grafts (SAGs) in U.S. Veterans. This study suggests promoting DAG use may benefit patients undergoing CABG surgery.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Vascular Surgery
Background:
- Coronary artery bypass grafting (CABG) is a common procedure for coronary artery disease.
- The use of dual arterial grafts (DAGs) versus single arterial grafts (SAGs) in CABG remains debated regarding long-term clinical benefits.
- This study compares outcomes of DAGs (bilateral internal thoracic artery or internal thoracic artery/radial artery) versus SAGs in U.S. Veterans.
Purpose of the Study:
- To compare the long-term clinical outcomes of dual arterial grafts (DAGs) versus single arterial grafts (SAGs) in U.S. Veterans undergoing isolated on-pump CABG.
- To evaluate the impact of different DAG configurations (bilateral internal thoracic artery vs. internal thoracic artery/radial artery) on patient outcomes.
Main Methods:
- A cross-sectional study was conducted using data from 25,969 U.S. Veterans undergoing isolated on-pump CABG between 2005 and 2015 at 44 VA medical centers.
- The primary outcome was a composite of major adverse cardiac and cerebrovascular events (MACCE), including death, myocardial infarction, stroke, or repeat revascularization.
- Follow-up was conducted over 5 years.
Main Results:
- Dual arterial grafts (DAGs) were used in 4.9% of patients, with 66.8% being internal thoracic artery/radial artery (DAG-RA) and 33.2% bilateral internal thoracic artery (DAG-BITA).
- Compared to SAGs, DAGs were associated with significantly lower rates of all-cause death, MACCE, and stroke.
- DAG-BITA showed a greater benefit, with significantly lower rates of death and MACCE compared to SAGs, while DAG-RA also demonstrated a reduction in all-cause death.
Conclusions:
- Dual arterial grafting (DAG) is associated with improved long-term MACCE outcomes compared to single arterial grafting (SAG) in the U.S. Veterans Affairs healthcare system.
- These findings support the increased use of DAGs in CABG procedures within the VA system.
- Promoting DAG use may enhance long-term benefits for Veterans undergoing coronary artery bypass surgery.
Introduction:
Controversy surrounds the long-term clinical benefit of coronary artery bypass grafting (CABG) using dual arterial grafts (DAGs) compared to single arterial grafts (SAGs). We investigated outcomes of DAG, using single internal thoracic artery and radial artery (DAG-RA) or bilateral internal thoracic artery grafts (DAG-BITA), compared to SAG, using the left internal thoracic artery and saphenous vein grafts, in the U.S. Veterans Health Administration (VA).
Methods:
We conducted a cross-sectional study of U.S. Veterans undergoing isolated on-pump CABG between 2005 and 2015 at 44 VA medical centers. The primary composite outcome was first occurrence of a major adverse cardiac and cerebrovascular event (MACCE), comprised of death from any cause, myocardial infarction, stroke, or repeat revascularization.
Results:
Among 25,969 Veterans undergoing isolated CABG, 1261 (4.9%) underwent DAG (66.8% DAG-RA and 33.2% DAG-BITA). Over a 5-y follow-up, DAG was associated with lower rates of all-cause death (adjusted hazard ratio [AHR] 0.70, 95% confidence interval [CI] 0.58-0.85), MACCE (AHR 0.80, 95% CI 0.71-0.91), and stroke (AHR 0.74, 95% CI 0.57-0.96) versus SAG. DAG-BITA was associated with lower rates of all-cause death (AHR 0.52, 95% CI 0.35-0.77) and MACCE (AHR 0.66, 95% CI 0.51-0.84) than SAG, while DAG-RA was associated with lower rates of all-cause death (AHR 0.79, 95% CI 0.64-0.99).
Conclusions:
In the VA, DAG was associated with improved long-term MACCE outcomes compared to SAG. These results suggest that the practice of DAG in the VA benefits Veterans and should be promoted further.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management

